LifePoint Health, Inc. (NASDAQ:LPNT) – Leerink Swann dropped their FY2017 EPS estimates for shares of LifePoint Health in a report released on Monday. Leerink Swann analyst A. Gupte now forecasts that the company will earn $3.58 per share for the year, down from their previous forecast of $4.09. Leerink Swann currently has a “Outperform” rating and a $58.00 price objective on the stock. Leerink Swann also issued estimates for LifePoint Health’s Q4 2017 earnings at $0.75 EPS, FY2018 earnings at $3.85 EPS and FY2019 earnings at $4.20 EPS.

LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing analysts’ consensus estimates of $0.95 by ($0.15). The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm’s quarterly revenue was down .7% compared to the same quarter last year. During the same period last year, the company posted $0.94 earnings per share.

WARNING: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/02/fy2017-earnings-estimate-for-lifepoint-health-inc-issued-by-leerink-swann-lpnt.html.

Several other analysts have also recently weighed in on the company. BidaskClub cut LifePoint Health from a “buy” rating to a “hold” rating in a research report on Saturday, July 8th. ValuEngine cut LifePoint Health from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Zacks Investment Research raised LifePoint Health from a “sell” rating to a “hold” rating in a research report on Monday, September 11th. Piper Jaffray Companies reaffirmed a “hold” rating and set a $66.00 price objective on shares of LifePoint Health in a research report on Wednesday, October 4th. Finally, SunTrust Banks, Inc. set a $60.00 price objective on LifePoint Health and gave the company a “hold” rating in a research report on Thursday, October 12th. Three analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $60.57.

Several institutional investors and hedge funds have recently modified their holdings of LPNT. BlackRock Inc. boosted its position in shares of LifePoint Health by 11,671.9% in the 1st quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock worth $245,351,000 after purchasing an additional 3,714,004 shares in the last quarter. LSV Asset Management boosted its position in shares of LifePoint Health by 83.5% in the 2nd quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock worth $133,934,000 after purchasing an additional 907,469 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of LifePoint Health by 130.6% in the 2nd quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock worth $54,804,000 after purchasing an additional 462,211 shares in the last quarter. American Century Companies Inc. boosted its position in shares of LifePoint Health by 7.7% in the 3rd quarter. American Century Companies Inc. now owns 3,630,487 shares of the company’s stock worth $210,205,000 after purchasing an additional 260,944 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of LifePoint Health by 103.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 408,284 shares of the company’s stock worth $26,742,000 after purchasing an additional 208,084 shares in the last quarter. 99.53% of the stock is currently owned by hedge funds and other institutional investors.

LifePoint Health announced that its Board of Directors has approved a share repurchase program on Friday, October 27th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company’s leadership believes its stock is undervalued.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.